Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Monte Rosa Therapeutics (GLUE) operate in?

Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Monte Rosa Therapeutics Stock (NASDAQ: GLUE) stock price, news, charts, stock research, profile.

Open	$3.32
Close	$3.74
Volume / Avg.	579.36K / 199.02K
Day Range	3.21 - 3.74
52 Wk Range	2.44 - 8.84
Market Cap	$229.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	5.94%
Days to Cover	8.39

Recent News

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

Avi Kapoor

Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst

Wedbush initiates coverage on Monte Rosa Therapeutics. With differentiated lead programs and AI-driven QuEEN platform, the company shows strong potential for value creation.

Vandana Singh

Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Monte Rosa Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Monte Rosa Therapeutics (GLUE) stock?

You can purchase shares of Monte Rosa Therapeutics (NASDAQ:GLUE) through any online brokerage.

View our list of the best stock brokerages

Who are Monte Rosa Therapeutics (GLUE) competitors?

Other companies in Monte Rosa Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Skye Bioscience (NASDAQ:SKYE), Inovio Pharmaceuticals (NASDAQ:INO) and Genfit (NASDAQ:GNFT).

What is the target price for Monte Rosa Therapeutics (GLUE) stock?

There is no analysis for Monte Rosa Therapeutics.

What is the forecast for Monte Rosa Therapeutics (GLUE) stock?

Monte Rosa Therapeutics has a consensus price target of $17.78.

Current stock price for Monte Rosa Therapeutics (GLUE)?

The stock price for Monte Rosa Therapeutics (NASDAQ: GLUE) is $3.75 last updated June 28, 2024 at 4:06 PM EDT.

Does Monte Rosa Therapeutics (GLUE) pay a dividend?

There are no upcoming dividends for Monte Rosa Therapeutics.

When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?

Monte Rosa Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Monte Rosa Therapeutics (GLUE) going to split?

There is no upcoming split for Monte Rosa Therapeutics.

What sector and industry does Monte Rosa Therapeutics (GLUE) operate in?

Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Monte Rosa Therapeutics

Monte Rosa Therapeutics (GLUE) Forecast